Skip to search formSkip to main contentSkip to account menu

2'-carbomethoxyphenyl 4-guanidinobenzoate

Known as: MSGB 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Guanidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
FRI0323 A “Composite-Index” Approach for Defining Salivary Gland Inflammation, Dysfunction and Its Impact on Patient-Reported Outcomes: A Role for Salivary Gland Ultrasonography?
Objectives To investigate the role of salivary gland ultrasonography (SGUS) in a composite index for the assessment of glandular… 
Review
2013
Review
2013
OP0148 Peripheral Neuropathy (PN) in Primary Sjögren’s Syndrome: Implications of Clinical Assessment, Time of Diagnosis and Treatment
Background Clinical evidence of Primary Sjögren’s Syndrome (pSS) includes sicca symptoms, autoantibodies, physical exam evidence… 
Review
2013
Review
2013
SAT0217 Diagnostic value of labial minor salivary gland biopsy for primary sjögren’s syndrome: A systematic review
Background The minor salivary gland biopsy (MSGB) plays a preponderant role in the American European Consensus Group (AECG… 
1990
1990
The lack of mutagenicity of aryl 4-guanidinobenzoates in the transplacental micronucleus assay in mice.
1988
1988
Development of the polyurethane sponge as a delivery system for aryl 4-guanidinobenzoates.
1988
1988
Development of a polymeric releasing device for 2'-carbomethoxyphenyl 4-guanidinobenzoate (a proteinase inhibitor): release rate, in vitro antifibrinolytic activity and in utero contraceptive effect.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)